Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)Kantarjian, Hagop M. ; Begna, Kebede H. ; Altman, Jessica K. ; Goldberg, Stuart L. ; Sekeres, Mikkael A. ; Strickland, Stephen A. ; Arellano, Martha L. ; Claxton, David F. ; Baer, Maria R. ; Gautier, Marc ; Berman, Ellin ; Seiter, Karen ; Solomon, Scott R. ; Schiller, Gary J. ; Luger, Selina M. ; Butrym, Aleksandra ; Gaidano, Gianluca ; Thomas, Xavier G. ; Montesinos, Pau ; Rizzieri, David A. ; Quick, Donald P. ; Venugopal, Parameswaran ; Gaur, Rakesh ; Maness, Lori J. ; Kadia, Tapan M. ; Ravandi, Farhad ; Buyse, Marc E. ; Chiao, Judy H.Cancer, 2021-12, Vol.127 (23), p.4421-4431 [Periódico revisado por pares]United States: Wiley Subscription Services, IncTexto completo disponível |
|
2 |
Material Type: Artigo
|
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cellsJORDAN, C. T ; UPCHURCH, D ; LUGER, S. M ; PHILLIPS, G. L ; SZILVASSY, S. J ; GUZMAN, M. L ; HOWARD, D. S ; PETTIGREW, A. L ; MEYERROSE, T ; ROSSI, R ; GRIMES, B ; RIZZIERI, D. ALeukemia, 2000-10, Vol.14 (10), p.1777-1784 [Periódico revisado por pares]London: Nature PublishingTexto completo disponível |
|
3 |
Material Type: Artigo
|
A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemiaBorthakur, Gautam ; Odenike, Olatoyosi ; Aldoss, Ibrahim ; Rizzieri, David A. ; Prebet, Thomas ; Chen, Chris ; Popovic, Relja ; Modi, Dimple A. ; Joshi, Rujuta H. ; Wolff, Johannes E. ; Jonas, Brian A.Cancer, 2021-08, Vol.127 (16), p.2943-2953 [Periódico revisado por pares]United States: Wiley Subscription Services, IncTexto completo disponível |
|
4 |
Material Type: Artigo
|
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysisMichelis, Fotios V. ; Gupta, Vikas ; Zhang, Mei‐Jie ; Wang, Hai‐Lin ; Aljurf, Mahmoud ; Bacher, Ulrike ; Beitinjaneh, Amer ; Chen, Yi‐Bin ; DeFilipp, Zachariah ; Gale, Robert Peter ; Kebriaei, Partow ; Kharfan‐Dabaja, Mohamed ; Lazarus, Hillard M. ; Nishihori, Taiga ; Olsson, Richard F. ; Oran, Betul ; Rashidi, Armin ; Rizzieri, David A. ; Tallman, Martin S. ; de Lima, Marcos ; Khoury, H. Jean ; Sandmaier, Brenda M. ; Weisdorf, Daniel ; Saber, WaelCancer, 2017-06, Vol.123 (11), p.2035-2042 [Periódico revisado por pares]United States: Wiley Subscription Services, IncTexto completo disponível |
|
5 |
Material Type: Artigo
|
Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemiaRoboz, Gail J. ; Kantarjian, Hagop M. ; Yee, Karen W. L. ; Kropf, Patricia L. ; O'Connell, Casey L. ; Griffiths, Elizabeth A. ; Stock, Wendy ; Daver, Naval G. ; Jabbour, Elias ; Ritchie, Ellen K. ; Walsh, Katherine J. ; Rizzieri, David ; Lunin, Scott D. ; Curio, Tania ; Chung, Woonbok ; Hao, Yong ; Lowder, James N. ; Azab, Mohammad ; Issa, Jean‐Pierre J.Cancer, 2018-01, Vol.124 (2), p.325-334 [Periódico revisado por pares]United States: Wiley Subscription Services, IncTexto completo disponível |
|
6 |
Material Type: Artigo
|
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AMLGarcia-Manero, Guillermo ; Podoltsev, Nikolai A ; Othus, Megan ; Pagel, John M ; Radich, Jerald P ; Fang, Min ; Rizzieri, David A ; Marcucci, Guido ; Strickland, Stephen A ; Litzow, Mark R ; Savoie, M Lynn ; Medeiros, Bruno C ; Sekeres, Mikkael A ; Lin, Tara L ; Uy, Geoffrey L ; Powell, Bayard L ; Kolitz, Jonathan E ; Larson, Richard A ; Stone, Richard M ; Claxton, David ; Essell, James ; Luger, Selina M ; Mohan, Sanjay R ; Moseley, Anna ; Appelbaum, Frederick R ; Erba, Harry PLeukemia, 2024-01, Vol.38 (1), p.58-66 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
7 |
Material Type: Artigo
|
Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transferHOWARD, D. S ; RIZZIERRI, D. A ; GRIMES, B ; UPCHURCH, D ; PHILLIPS, G. L ; STEWART, A. K ; YANNELLI, J. R ; JORDAN, C. TLeukemia, 1999-10, Vol.13 (10), p.1608-1616 [Periódico revisado por pares]London: Nature PublishingTexto completo disponível |
|
8 |
Material Type: Artigo
|
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemiaKhalife, J ; Radomska, H S ; Santhanam, R ; Huang, X ; Neviani, P ; Saultz, J ; Wang, H ; Wu, Y-Z ; Alachkar, H ; Anghelina, M ; Dorrance, A ; Curfman, J ; Bloomfield, C D ; Medeiros, B C ; Perrotti, D ; Lee, L J ; Lee, R J ; Caligiuri, M A ; Pichiorri, F ; Croce, C M ; Garzon, R ; Guzman, M L ; Mendler, J H ; Marcucci, GLeukemia, 2015-10, Vol.29 (10), p.1981-1992 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
9 |
Material Type: Artigo
|
Acute Myeloid LeukemiaDöhner, Hartmut ; Weisdorf, Daniel J ; Bloomfield, Clara D Longo, Dan L ; Longo, Dan L.The New England journal of medicine, 2015-09, Vol.373 (12), p.1136-1152 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
|
10 |
Material Type: Artigo
|
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survivalCabezón, M ; Malinverni, R ; Bargay, J ; Xicoy, B ; Marcé, S ; Garrido, A ; Tormo, M ; Arenillas, L ; Coll, R ; Borras, J ; Jiménez, M J ; Hoyos, M ; Valcárcel, D ; Escoda, L ; Vall-Llovera, F ; Garcia, A ; Font, L L ; Rámila, E ; Buschbeck, M ; Zamora, LClinical epigenetics, 2021-01, Vol.13 (1), p.9-9, Article 9 [Periódico revisado por pares]Germany: BioMed Central LtdTexto completo disponível |